Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GCP
5301
DELISTED
GCP Applied Technologies Inc.
GCP
| $2.15M | ﹤0.01% |
68,618
-12,896
| -16% | -$402K |
|
5302
Helen of Troy
HELE
$675M
| $2.15M | ﹤0.01% |
13,209
-3,746
| -22% | -$706K |
|
|
WW
5303
DELISTED
WW International
WW
| $2.14M | ﹤0.01% |
335,481
+146,045
| +77% | +$1.23M |
|
5304
ANI Pharmaceuticals
ANIP
$1.77B
| $2.14M | ﹤0.01% |
72,216
+64,228
| +804% | +$1.85M |
|
|
CIR
5305
DELISTED
CIRCOR International, Inc
CIR
| $2.14M | ﹤0.01% |
130,680
+73,339
| +128% | +$1.47M |
|
5306
CALL
Celanese
CE
$4.83B
| $2.14M | ﹤0.01% |
18,200
-2,200
| -11% | -$316K |
|
5307
Upland Software
UPLD
$15.7M
| $2.14M | ﹤0.01% |
14,741
+6,737
| +84% | +$984K |
|
5308
CALL
VanEck High Yield Muni ETF
HYD
$4.37B
| $2.14M | ﹤0.01% |
39,700
+23,500
| +145% | +$1.28M |
|
5309
MYR Group
MYRG
$5.3B
| $2.14M | ﹤0.01% |
24,258
+15,024
| +163% | +$1.32M |
|
5310
CALL
Eagle Materials
EXP
$6.3B
| $2.13M | ﹤0.01% |
19,400
-99,900
| -84% | -$12.3M |
|
5311
CALL
Global X Russell 2000 Covered Call ETF
RYLD
$1.4B
| $2.13M | ﹤0.01% |
103,700
+9,700
| +10% | +$211K |
|
5312
State Street SPDR S&P Aerospace & Defense ETF
XAR
$6.7B
| $2.13M | ﹤0.01% |
+21,137
| New | +$2.33M |
|
|
RCOR
5313
DELISTED
Renovacor, Inc.
RCOR
| $2.13M | ﹤0.01% |
1,049,014
-5,392
| -0.5% | -$14.3K |
|
5314
OGE Energy
OGE
$9.77B
| $2.13M | ﹤0.01% |
55,139
+42,422
| +334% | +$1.69M |
|
5315
CALL
PIMCO 25+ Year Zero Coupon US Treasury Index Exchange-Traded Fund
ZROZ
$1.32B
| $2.12M | ﹤0.01% |
19,600
+11,600
| +145% | +$1.3M |
|
|
ICPT
5316
CALL
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $2.12M | ﹤0.01% |
153,700
-7,900
| -5% | -$126K |
|
5317
Ameriprise Financial
AMP
$50.2B
| $2.12M | ﹤0.01% |
8,926
+7,599
| +573% | +$2.04M |
|
5318
PUT
SouthState Bank Corp
SSB
$10.9B
| $2.12M | ﹤0.01% |
27,500
-6,400
| -19% | -$499K |
|
|
SWIR
5319
CALL
DELISTED
Sierra Wireless
SWIR
| $2.12M | ﹤0.01% |
90,700
+8,400
| +10% | +$165K |
|
5320
CALL
Vanguard Total International Bond ETF
BNDX
$82.7B
| $2.12M | ﹤0.01% |
+42,800
| New | +$2.16M |
|
5321
First Financial Bancorp
FFBC
$3.62B
| $2.12M | ﹤0.01% |
109,266
+94,111
| +621% | +$1.96M |
|
5322
eHealth
EHTH
$39.4M
| $2.12M | ﹤0.01% |
227,153
+45,577
| +25% | +$464K |
|
5323
Ultrapar
UGP
$6.82B
| $2.12M | ﹤0.01% |
901,687
+48,731
| +6% | +$133K |
|
|
ATRI
5324
DELISTED
Atrion Corp
ATRI
| $2.12M | ﹤0.01% |
3,369
-175
| -5% | -$114K |
|
5325
PUT
SL Green Realty
SLG
$3.93B
| $2.12M | ﹤0.01% |
45,896
+9,526
| +26% | +$606K |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.